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Abstract
Background: This study was conducted to investigate the expression of CXCR4 in portal vein tumor thrombus
(PVTT) tissue and its possible role in the invasiveness of tumor thrombus cells.
Methods: We detected differential expression of CXCR4 between PVTT and hepatocellular carcinoma (HCC) by an
immunohistochemical assay. Lentivirus-mediated RNA interference and a migration assay were performed on
human primary cells derived from PVTT to study the impact of CXCR4 on the invasiveness of HCC.
Results: The expression of CXCR4 in tumor thrombus tissue was higher than that in HCC tissue. The invasion ratio
of PVTT cells was significantly decreased (P < 0.05) after being infected with a CXCR4-targeting siRNA lentivirus,
indicating that downregulation of CXCR4 by lentivirus-mediated RNA interference significantly impaired the
invasive potential of PVTT.
Conclusions: These results indicate that CXCR4 is an effective curative target for hepatocellular carcinomas with
PVTT.
Background
Hepatocellular carcinoma (HCC) is an extremely com-
mon malignant tumor. China is developing one of the
highest incidences of liver cancer worldwide. About 45%
of de novo HCC cases were discovered in mainland
China, and about 110, 000 people died of hepatoma. In
fact, in Asian countries such as China, India, the Repub-
lic of Korea, Singapore and Vietnam, more than 80% to
90% cases of HCC were associated with human hepatitis
B virus (HBV) infections. More than 2 billion people
have been infected with HBV worldwide, and more than
350 million of these people became infectors; 75% of all
infectors live in Asia, and 33% live in mainland China
[1,2]. In fact, chronic HBV infection greatly increases
the risk of liver cirrhosis and HCC, resulting in the
deaths of nearly one million HBV infectors from a
variety of liver diseases, such as hepatic failure, hepatic
cirrhosis and HCC.
For the past several years, even though the therapy
provided to HCC patients has greatly improved, most
patients in the middle and advanced stages of HCC
have generated portal vein metastases, which form por-
tal vein tumor thrombi (PVTT)[3]. The resected sample
ratio of clinical surgery for the liver is relatively low,
and the recurrence ratio after surgery is relatively high
[4]. Overall, the total curative effect in these cases is not
as good as expected. The most common reason for car-
cinoma metastasis is that the cancer cells grow toward
the portal vein, which leads to the formation of PVTT.
Studies on the mechanisms of tumor formation and
metastasis are hindered by difficulties with the corre-
sponding HCC cell lines [5].
The CXCR4 protein is a G protein-coupled, seven-trans-
membrane receptor. The chemokine CXCL12, also called
stromal-derived factor (SDF-1), is the sole ligand for
CXCR4 [6]. Unlike other chemokines and their receptors,
CXCR4 and SDF-1 are constitutively expressed in a variety
of tissues, including the brain, heart, liver, lung, spleen and
kidney [1,7,8]. SDF-1 is expressed in hematopoietic and
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non-hematopoietic tissues and was originally identified
from bone marrow stromal cells as a pre-B cell growth
factor, which is essential for heart, nervous system and
blood vessel development. Mice with a targeted deletion of
the CXCL12 gene die perinatally, whereas the CXCR4
protein is expressed mainly in neutrophilic granulocytes,
macrophages and dendritic cells. The interaction between
CXCR4 and SDF-1 plays an important role in the forma-
tion of embryos, the development of blood vessels and the
heart, the homing of hematopoietic stem cells after trans-
plant, the transmembrane migration of inflammatory cells,
T lymphocyte proliferation and the inflammatory
response. After further research on the receptor, investiga-
tors found that CXCR4 is one of the most comprehensive
cytokine receptors expressed in tissue, playing an impor-
tant role in the growth and metastasis of a variety of
malignant tumors [9].
In this article, through in vitro primary culture meth-
ods, we obtained an HCC cell line derived from the
human hepatoma portal vein, which provided the
experimental materials for a functional study of the role
of CXCR4 in tumor cell invasiveness. To confirm the
novel role of CXCR4 in hepatocarcinogenesis, the
expression levels of CXCR4 in tumor tissue, adjacent
hepatic tissue and PVTT tissue were measured. Finally,
the mutual effects of CXCR4 expression and clinical
pathology characteristics were discussed [10]. To further
investigate the role of CXCR4 in HCC tumorigenesis
and metastasis, a migration assay was performed on
PVTT cells following the suppression of CXCR4 expres-




Patient sample exhibiting HCC with PVTT
A total of 23 cases originated from the resected sample
of HCC of active hepatitis combined with PVTT in the
Eastern Hepatobiliary Surgery Hospital from May 2007
to May 2008. Of all of the cases, 14 cases were male
and 9 were female, and the ages ranged from 28 to 66
years, with an average age of 42. The detection of hepa-
titis B DNA in all patients was greater than 104 (104-
107) copies/ml. Nineteen of the patients had HbsAg (+),
HbeAg (+) and HbcAg (+), which accounted for 82.6%
of the patients; 4 cases were HbsAg (+), HbeAb (+),
HbcAg (+), which accounted for 17.4%. There were 7
cases with complicating lesser tubercle hepatic cirrhosis,
10 cases with tuberculum majus liver cirrhosis, and 6
cases with mixed tuberculum liver cirrhosis. Seventeen
cases had serum alpha-fetoprotein levels of greater than
20 μg/L (upper normal level), which accounts for
73.9%. There were 10 cases in which the hepatoma were
located in the lobus sinister, whereas 10 cases had
hepatomas in the right lobe and 5 in the middle lobe.
According to the Edmondson grading standard, 1 case
was grade II, 21 cases were grade III and 1 case was
grade IV; 9 cases had a tumor diameter of less than 5
cm, whereas 14 cases had a diameter greater than 5 cm.
Four cases were amicula-integrated patients, and the
other 19 patients were amicula-incomplete cases. All
patients had PVTT that was visible to the naked eye.
The 23 pairs of samples of tumor tissue, the corre-
sponding adjacent tissue and the PVTT tissue were all
stained by immunohistochemical staining.
Patients with HCC without PVTT
A total of 17 cases originated from the resected sample
of HCC of active hepatitis without PVTT in the Eastern
Hepatobiliary Surgery Hospital from May 2007 to May
2008 (at the same period as the PVTT group). Of all of
the cases, 11 were male and 6 were female, and the ages
ranged from 31 to 67 years, with an average age of 48.
The detection of hepatitis B DNA in all patients was
greater than 104 (104-107) copies/ml. Among the cases,
12 (70.6%) were HbsAg (+), HbeAg (+) and HbcAg (+),
whereas 5 (29.4%) were HbsAg (+), HbeAb (+) and
HbcAg (+). All the cases were cirrhosis-infected. There
were 5 cases of complicating lesser tubercle hepatic cir-
rhosis, 7 cases of tuberculum majus liver cirrhosis, and
5 cases of mixed tuberculum liver cirrhosis. There were
13 cases (76.5%) in which serum alpha-fetoprotein levels
were greater than 20 μg/L (upper normal level). Eleven
cases of hepatoma were located in the lobus sinister,
whereas 11 cases were located in the right lobe of the
liver and 3 cases in the middle lobe of the liver. Accord-
ing to the Edmondson grading standard, two cases were
grade II and 15 cases were grade III; there were 3 cases
whose tumor diameter was less than 5 cm and 14 cases
greater than 5 cm. Five cases were amicula-integrated,
and the other 12 cases were amicula-uncompleted. All
patients were free from PVTT. The 17 pairs of samples
of tumor tissue and the corresponding adjacent tissue
were all stained by immunohistochemical staining.
Reagents and antibodies
The monoclonal antibody for CXCR4 was purchased
from R&D Co. Ltd. The SP (streptavidin-peroxidase) kit
was the product of the Zymed Co. Ltd. and was pur-
chased from Beijing Zhongshan Biotechnology Co. Ltd.
The following primary antibodies were used: mouse
anti-human IgG (R&D) and HRP-conjugated goat anti-
mouse secondary antibody (Zymed). All of the other
common chemical reagents were purchased from Sigma.
Immunohistochemical assay
Streptavidin-peroxidase methods were used. Tissue
slices were dewaxed and then washed out. The sections
were washed three times with PBS for 5 min. After
treatment with 3% H2O2 solution for 10 minutes, the
sections were incubated overnight with anti-CXCR4
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antibody (1:100, R&D Co. Ltd) at 4°C. The sections were
then washed in PBS and incubated for 1 hour with
HRP-conjugated goat anti-mouse secondary antibodies
(1:5000, Zymed Co. Ltd). Coloration was achieved
through staining with DAB for 3 min. After a series of
water-poaching procedures, hematoxylin counterstaining
and neutral gum mounting, fluorescent signals were
examined using an LSM 5 PASCA1 laser-scanning con-
focal microscope.
Evaluating standard
The slices were examined in a double-blind manner by
two different pathologists, and the scores were supplied
by the proportion of positive tumor cells and the inten-
sity of the coloring. The standards were defined as fol-
lows using the ratio of masculine tumor cells: 0 points
represented less than 5%, 1 point represented 5% to
25%, 3 points represented 50% to 75% and 4 points
represented greater than 75%. However, the groups
could also be classified into the following 4 groups by
the intensity of the coloring: 0 represented no coloring,
1 represented stramineous, 2 represented yellow and 3
represented buffy. The products of double multiplication
indicated the extent of the cancer. Scores equal to 0
indicate negative (-), whereas scores exceeding 1 indi-
cate positive and scores from 1 to 3 indicate weakly
positive (+), 4 to 7 indicate positive (++), and 8 to 12
indicate hadro-positive (+++).
Primary hepatoma cells from PVTT
Primary hepatoma cells were prepared from specimens of
fresh HCC and PVTT obtained from surgery. The speci-
mens were submerged into RPMI-1640 nutrient solution
with antibiotic and then sent to the laboratory at 4°C, fol-
lowed by the aseptic processing and rejection of blood
vessels, amicula, dirty blood and necrotic tissue. The spe-
cimens were then cut to 1.0 mm3 and thoroughly washed
in D-Hank’s solution [11]. The tissues were sheared into
starch paste by asepsis scissors. Collagenase solution was
added and allowed to digest for 15 to 30 min in a vibrat-
ing homeothermia bath, followed by filtration through a
cyto-screen (d = 72 μm) and the removal of undigested
tissue. Cells were inoculated into plastic Petri dishes;
RPMI-1640 was added to the mixture in 5% CO2, per-
fused at 37°C, and then transferred to a 35-mm dish until
the cells occupied 80% of the plate.
RNAi constructs and gene silencing of CXCR4
A CXCR4-targeting short-hairpin RNA (shRNA)
sequence, together with a miRNA-30 loop, was inserted
into pGCSIL-GFP vector via AgeI and EcoRI sites.
CXCR4-shRNA sequences were designed to target
human CXCR4 mRNA (NM_001008540.1). The corre-
sponding virus vector shRNA target was as follows: the
sense sequence of the target, from 5’ to 3’, was CCGGAA-
GATGATGGAGTAGATGGTGTTCAAGAGAC
ACCATCTACTCCATCATCTTTTTTTG; the antisense
sequence, from 3’ to 5’, was ATTCAAAA AAAGAT-
GATGGAGTAGATGGTGTCTCTTGAACAC-
CATCTCTCCATCATCT. The negative control was a
hairpin sequence targeting the firefly luciferase gene
inserted into the same plasmid at the same sites (Gene-
chem Co. Ltd., Shanghai). The pEGFP-N1-3FLAG vector
was used for the construction of an overexpression system
for CXCR4 [8]. XhoI and KpnI were the inserting sites.
The sequence of CXCR4-XhoI-F was CCGCTCGA-
GATGTCCATTCCTTTGCCTC from 5’ to 3’. The
sequence of CXCR4-KpnI-R was CGGGGTACCGTG-
CTGGAGTGAAAACTTGAAG. These two sequences
were used to determine the objective gene by PCR meth-
ods [7]. The CXCR4 gene, as amplified by PCR, was com-
pletely in accord with sequencing results.
Lentivirus infection and migration assay
Primary cells were plated in six-well plates (5 × 104
cells/well) until cell fusion reached 60%. Then, accord-
ing to the MOI value (number of lentiviruses per num-
ber of cells), appropriate volumes of lentivirus were
added to the cells. After 24 h of infection at 37°C, the
medium was replaced by fresh medium and incubated
for a further 48 h.
The recombinant lentivirus bearing siRNA targeting
CXCR4 and the negative control lentivirus were trans-
ferred. For the cell migration assay, 1 × 104 cells from
different groups were seeded on a fibronectin-coated
polycarbonate membrane insert (6.5 mm in diameter
with 8.0-μm pores) in a transwell apparatus and cul-
tured in RPMI-1640. FBS was added to the lower cham-
ber. After incubation for 14 h, the cells on the top
surface of the insert were removed by wiping with a cot-
ton swab. Cells that migrated to the bottom surface of
the insert were fixed with methanol and stained by
Giemsa and then subjected to microscopic inspection.
Statistical Analysis
Student’s t-test and ANOVA were used to compare dif-
ferences in the measurement data among different
groups. The chi-squared test was used to compare dif-
ferences in the rates and proportions between different
groups. Regarding the difference comparison of ranked
data, the Mann-Whitney nonparametric statistical
method was used; P < 0.05 was considered significant,
and SPSS 10.0 was used for all analyses. Data are pre-
sented as the means ± SD or n/%.
Results
CXCR4 expression in tumor tissue and adjacent liver
tissue of HCC with PVTT
Of the 23 specimens of HCC tissue that were stained by
immunohistochemistry, 17 (73.9%) exhibited negative
staining (Figure 1A). Six samples were positive (Figure
1B and 1C), and the positive ratio was 26.1%. In these
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samples, 4 were stained as weakly positive, 2 were mas-
culine positive, and CXCR4 was located mainly in the
membrane and cytoplasm of hepatoma cells.
The results in the 23 specimens of adjacent liver tis-
sues were quite different. Three cases displayed negative
staining after CXCR4 immunohistochemistry, 20 sam-
ples were positive, and the ratio of positive staining was
86.0%. The expression of CXCR4 was also mainly
detected in the cell membrane and cytoplasm of
inflamed hepatic tissue (Figure 1D). As was also
expressed in the nucleus (Figure 1E), part of the bile
canaliculi endothelial cells and hepatic sinusoid
endothelial tissue (Figure 1F and 1G), as well as positive
CXCR4, were also observed.
Figure 1 The expression of CXCR4 in tumor tissue and adjacent liver tissue reflects the characteristic pathology of cancer. (A-C)
Representative images of CXCR4 staining. Tumor tissue was treated with the CXCR4 antibody. The red cells are represented as CXCR4-positive
cells. (A) Negative CXCR4-staining cells; (B) Weakly positive staining cells; (C) Positive staining cells. Statistical analysis indicated that 73.9% of all
23 cases were negative, and 6 cases, which occupied 26.1% of all cases, were positive. Magnification: ×200. (D) Representative images of CXCR4
staining. Adjacent liver tissue was treated with the CXCR4 antibody. The red cells indicate CXCR4-positive cells. The CXCR4 cells expressed in
inflamed hepatic tissue were mainly located in the cell membrane and cytoplasm. Magnification: 400×. (E-G) CXCR4-positive cells expressed in
inflamed hepatic tissue. (E) CXCR4-positive cells located in the liver nucleus; (F) CXCR4-positive cells located in bile canaliculi endothelial cells; (G)
CXCR4-positive cells located in hepatic sinusoid endothelial tissue. Magnification: ×400. (H) Negative CXCR4 staining in HCC tissue without PVTT.
(I) Positive CXCR4 staining in HCC tissue without PVTT. (J-K) The percentage of positive CXCR4-cells expressed in PVTT tissue is 52.2%. In Figure J,
CXCR4 was stained as weakly positive, as opposed to Figure K, which showed positive staining. Magnification: ×200.
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The results of Hematoxylin & Eosin (HE) staining
on adjacent liver tissue indicated that the liver was
inflamed. The scores were derived from by a proportion
of CXCR4-positive cells and coloring intensity to HCC
and adjacent liver specimens. The results indicate that
the expression levels of CXCR4 in HCC tissue and adja-
cent liver cells were quite different. We demonstrated
that the expression of CXCR4 in adjacent inflammatory
liver tissue was dramatically higher than that in tumor
tissue (Table 1 P < 0.05).
CXCR4 expression in tumor tissue and adjacent liver
tissue of HCC without PVTT
In all 17 specimens of HCC tissue that were stained by
immunohistochemistry, 10 cases (58.8%) exhibited nega-
tive staining (Figure 1H). Seven samples were positive
(Figure 1I), and the positive ratio was 41.2%. In these
samples, three cases were stained as weakly positive for
CXCR4, and four cases were masculine positive (23.5%).
In the 17 specimens of adjacent liver tissues, four
cases (23.5%) displayed negative immunohistochemistry
staining for CXCR4, 13 samples were positive, and the
ratio of positive staining was 76.5%.
The results of HE staining on the adjacent liver
tissue indicated that the liver was inflamed. The scores
were determined by a proportion of CXCR4-positive
staining cells and coloring intensity to HCC and
adjacent liver specimens. The results indicate that the
expression levels of CXCR4 in HCC tissue and
adjacent liver cells were quite different. Specifically, we
found that the expression of CXCR4 in HCC tissue
was dramatically lower than that in adjacent liver tis-
sue (Table 2 P < 0.05).
CXCR4 expression in PVTT
In all 23 samples of PVTT tissue, 11 cases exhibited
negative immunohistochemistry staining for CXCR4, 12
samples were positive (Figure 1J and 1K), and the posi-
tive ratio was 52.2%. The total number of weakly posi-
tive and positive samples of CXCR4 expression samples
was five, and another two samples exhibited strongly
positive staining. Our results indicated that the expres-
sion of CXCR4 was mainly located in the membrane
and cytoplasm of tumor thrombus cells, which is consis-
tent with a previous report [3].
The positive cell ratio of CXCR4, the staining
color intensity of HCC, and tumor thrombus samples
were then scored. Previous reports demonstrated that
the expression levels of CXCR4 in different HCC tissues
and tumor thrombus tissues were quite different [12,13].
We confirmed that the expressions of CXCR4 in
tumor thrombus tissues was higher than in HCC tissues
(Table 3 p < 0.05).
CXCR4 expression of PVTT and clinicopathological
characteristics of HCC
There was no association between CXCR4 expression of
PVTT and the following clinicopathological characteris-
tics of HCC (Additional file 1: Table S1): age of patient,
sex of patient, Edmondson grading standard, tumor
location, tumor capsule, and liver function (P < 0.05).
However, CXCR4 expression was observed to be related
to tumor diameter (P > 0.05).
CXCR4 RNAi in primary hepatoma cells
First, we made a double-stranded DNA oligo with the
enzyme-cohesive end in the amphi side, which was
directly connected with the RNAi vector after digestion.
The construct was then transferred into competent bac-
terial cells and the positive clones were identified by
PCR. After sequencing, the positive clones were proven
to be successfully constructed for the lentivirus-vector
for RNA interference (RNAi). In this way, we successfully
made three shRNA constructs targeting CXCR4 [3,7].
We used PCR methods to acquire CXCR4 cDNA and
then cloned it into the pEGFP-N1 vector. The products
were transformed into competent bacterial cells, and
cloning was verified by PCR methods. After sequencing
and analyzing the PCR-derived positive clone, the GFP-
CXCR4 fusion protein-expressing plasmid was obtained.
To test the specificity of the RNAi constructs, we
cotransfected into HEK293T cells with the CXCR4 over-
expression and CXCR4 RNAi plasmids. After 24 h of
incubation, we used western blotting to detect the level
of CXCR4 expression (Figure 2A). Significant knock-
down of the target was confirmed [14].
Downregulation of CXCR4 inhibits cell migration
To explore the role of CXCR4 in hepatoma cells,
we performed an experiment with invasiveness in
Table 1 Differences in CXCR4 expression in adjacent liver tissue and tumor tissue of HCC with PVTT









Adjacent liver tissue 23 3 6 10 4 0.000Δ
Tumor tissue 23 17 4 2 0
ΔMann-Whitney test
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transwells in the 24-well culture plate using the cell
invasion assay kit. Invasion of the extracellular matrix
is an important component of tumor metastasis. The
tumor cells can adhere to the vessel wall and extend
along the wall. Proteinases such as MMP collagenase
could resolve the basilemma of the vessel so that the
malignant cells could gain the potential for invasion.
The CHEMION cell invasion assay kit provided us
with an effective system for the detection of malignant
cells crossing the basilemma. We found that the initial
inoculating cell numbers were about 20,000. In the
internal cell, the culture medium was 300 μL/pore,
whereas in the outer compartment, the culture med-
ium was about 500 μL/pore. After culture for 72 h, we
employed the MTT assay to find that the average
optical density (OD) value in the negative control
(infection of negative control of lentivirus cell) was
0.353. After Giemsa staining (Figure 2B), the average
OD value became 0.343, which means that the ratio of
invasion was 0.971, whereas in the CXCR4-knockdown
group the ratio of invasion was 0.747 (P < 0.05).
Therefore, we concluded that the knockdown of
CXCR4 could inhibit the cell migration of PVTT and
that CXCR4 may play a critical role in the metastasis
of PVTT.
Discussion
In this report, we investigated the differential expression
of CXCR4 between PVTT and HCC cells. The expres-
sion of CXCR4 in tumor thrombus tissue was higher
than in HCC tissue, which was consistent with high
expression of CXCR4 facilitating the characteristics of
metastasis [15,16]. The expression of CXCR4 in HCC
tissue was significantly lower than in carcinoma inflam-
matory liver tissue. As in the data of the group with
active hepatitis, the numbers of HBV DNA were all
greater than 104. Whether or not the adjacent liver
tissue was infected with PVTT, in inflammatory condi-
tions CXCR4 was highly expressed.
In the past several years, the establishment of a series
of human HCC cell lines provided an ideal in vitro
model to study the pathogenesis of liver cancer, metas-
tasis, development and therapy methods in molecular
biology. To explore the role of CXCR4 in carcinoma tis-
sue, the primary cells driven from PVTT have been
identified. The tumor cells were mostly derived from
the primary HCC tissues of patients. Few studies have
used PVTT for establishing cell lines; Hu et al. [15]
reported that the depletion of 8 bp in a chromosome
possibly corresponded with the formation of PVTT
when using primary cell culture methods on a PVTT
that was primarily focused in the liver, as determined by
karyotype analysis and comparative genomic hybridiza-
tion techniques. Our results confirmed one new HCC
cell line derived from human PVTT, which provided
sufficient experimental support for the study of the for-
mation mechanism of PVTT. In fact, there were nearly
no similar references on the establishment of PVTT cell
lines for human hepatoma cancer. Therefore, it is
important to study the formation and metastasis
mechanisms of PVTT in this primary cell line.
To gain insight into the role of CXCR4 in HCC
tumorigenesis and metastasis, we employed lentivirus-
mediated shRNA to knock down CXCR4 expression in
PVTT cells. After screening the siRNA targets, we
found the most significant knockdown targeting the
expression of CXCR4. The chemokine receptor CXCR4
is implicated in the metastasis of various cancers. The
association of CXCR4 expression with HCC bone
metastasis and patient survival was recently reported.
CXCR4 expression in primary HCCs may be an inde-
pendent risk factor for bone metastasis and associated
with poor clinical outcome [17]. Our transwell results
indicated that depletion of CXCR4 expression resulted
Table 2 Differences in CXCR4 expression in adjacent liver tissue and tumor tissue of HCC without PVTT









Adjacent liver tissue 17 4 5 7 1 0.044Δ
Tumor tissue 17 10 3 4 0
ΔMann-Whitney test
Table 3 Differences in CXCR4 expression in tumor thrombus tissue and tumor tissue









Adjacent liver tissue 23 11 5 5 2 0.044Δ
Tumor tissue 23 17 4 2 0
ΔMann-Whitney test
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in significant inhibition of PVTT cell migration. These
data extend the critical role of CXCR4 in promoting
the migration of cancer cells. The central role of
CXCR4 in cancer metastasis also raises the question of
whether CXCR4 can serve as an important diagnostic
target in the detection and treatment of cancer. Addi-
tionally, it is important to further establish the
mechanisms that result in increased CXCR4 expression
andpotentially target such pathways in cancer treat-
ment. Thus, understanding the mechanisms that nor-
mally regulate CXCR4 expression and function should
prove useful in the treatment and prevention of cancer
metastasis.
Conclusions
We determined that the expression of CXCR4 in PVTT
tissue was greater than that in liver cancer tissue and
that the downregulation of CXCR4 by RNA interference
significantly impaired the invasive ability of PVTT cells.
It is possible that CXCR4 plays a critical role in the
development of PVTT in HCC. The potential siRNA
target we screened may have an advantageous curative
effect on HCC.
Additional material
Additional file 1: Table S1: Association between CXCR4 expression
of PVTT and clinicopathological characteristics of HCC. CXCR4
expression of PVTT was observed to be related to tumor diameter. There
was no association between CXCR4 expression and the following
clinicopathological characteristics of HCC: age, sex, Edmondson grading,
tumor location, tumor capsule, and liver function.
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